Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:49 UTC |
---|
HMDB ID | HMDB0014983 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Clofazimine |
---|
Description | A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619) |
---|
Structure | CC(C)N=C1C=C2N(C3=CC=C(Cl)C=C3)C3=C(C=CC=C3)N=C2C=C1NC1=CC=C(Cl)C=C1 InChI=1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3 |
---|
Synonyms | Value | Source |
---|
(4-Chloro-phenyl)-[5-(4-chloro-phenyl)-3-isopropylimino-3,5-dihydro-phenazin-2-yl]-amine | ChEBI | 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine | ChEBI | 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin | ChEBI | Clofazimina | ChEBI | Clofaziminum | ChEBI | N,5-Bis(4-chlorophenyl)-3-(isopropylimino)-3,5-dihydrophenazin-2-amine | ChEBI | Chlofazimine | HMDB | Lamprene | HMDB | N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinamine | HMDB |
|
---|
Chemical Formula | C27H22Cl2N4 |
---|
Average Molecular Weight | 473.396 |
---|
Monoisotopic Molecular Weight | 472.122152138 |
---|
IUPAC Name | N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine |
---|
Traditional Name | clofazimina |
---|
CAS Registry Number | 2030-63-9 |
---|
SMILES | CC(C)N=C1C=C2N(C3=CC=C(Cl)C=C3)C3=C(C=CC=C3)N=C2C=C1NC1=CC=C(Cl)C=C1 |
---|
InChI Identifier | InChI=1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3 |
---|
InChI Key | WDQPAMHFFCXSNU-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenazines and derivatives. These are polycyclic aromatic compounds containing a phenazine moiety, which is a linear tricyclic system that consists of a two benzene rings joined by a pyrazine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazanaphthalenes |
---|
Sub Class | Benzodiazines |
---|
Direct Parent | Phenazines and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Phenazine
- Aniline or substituted anilines
- Chlorobenzene
- Halobenzene
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Pyrazine
- Heteroaromatic compound
- Secondary ketimine
- Azacycle
- Secondary amine
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Amine
- Organopnictogen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 210 - 212 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.0015 g/L | Not Available | LogP | 7 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Clofazimine,1TMS,isomer #1 | CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C2=CC=C(Cl)C=C2)C=C1N(C1=CC=C(Cl)C=C1)[Si](C)(C)C | 3958.4 | Semi standard non polar | 33892256 | Clofazimine,1TMS,isomer #1 | CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C2=CC=C(Cl)C=C2)C=C1N(C1=CC=C(Cl)C=C1)[Si](C)(C)C | 3544.1 | Standard non polar | 33892256 | Clofazimine,1TMS,isomer #1 | CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C2=CC=C(Cl)C=C2)C=C1N(C1=CC=C(Cl)C=C1)[Si](C)(C)C | 5060.6 | Standard polar | 33892256 | Clofazimine,1TBDMS,isomer #1 | CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C2=CC=C(Cl)C=C2)C=C1N(C1=CC=C(Cl)C=C1)[Si](C)(C)C(C)(C)C | 4104.5 | Semi standard non polar | 33892256 | Clofazimine,1TBDMS,isomer #1 | CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C2=CC=C(Cl)C=C2)C=C1N(C1=CC=C(Cl)C=C1)[Si](C)(C)C(C)(C)C | 3730.4 | Standard non polar | 33892256 | Clofazimine,1TBDMS,isomer #1 | CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C2=CC=C(Cl)C=C2)C=C1N(C1=CC=C(Cl)C=C1)[Si](C)(C)C(C)(C)C | 5051.3 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Clofazimine GC-MS (Non-derivatized) - 70eV, Positive | splash10-001l-2012900000-925bda9ffd357867fda8 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clofazimine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Clofazimine LC-ESI-qTof , Positive-QTOF | splash10-0zfr-0112112900-e3bfb9c4af77d4fe2af5 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clofazimine LC-ESI-qTof , Positive-QTOF | splash10-0f6t-2931000000-abbbe8c79a3a4d2e2a98 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clofazimine , positive-QTOF | splash10-00fr-0000900000-e6674066d4ff0d54220f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clofazimine , positive-QTOF | splash10-00ai-0122900000-6ab122b0d69d3063d257 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clofazimine 35V, Positive-QTOF | splash10-00di-0000900000-6208605751ff4198259d | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clofazimine 10V, Positive-QTOF | splash10-00dj-0004900000-53aaf2e9feab733f5696 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clofazimine 20V, Positive-QTOF | splash10-0002-0009300000-4e81c003ff635d972452 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clofazimine 40V, Positive-QTOF | splash10-000t-1009200000-1453a7404269fe261b3c | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clofazimine 10V, Negative-QTOF | splash10-00di-0000900000-a77f21de408c977df7c1 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clofazimine 20V, Negative-QTOF | splash10-00di-0000900000-6b7cc7e41f8ea912dd22 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clofazimine 40V, Negative-QTOF | splash10-004r-1303900000-1f018805b2b835da809b | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clofazimine 10V, Positive-QTOF | splash10-00di-0000900000-4bc61438169d333cca7c | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clofazimine 20V, Positive-QTOF | splash10-00di-0000900000-f04a0f2b905ba555c653 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clofazimine 40V, Positive-QTOF | splash10-001j-0009600000-38a02d9b4caf79a840c7 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clofazimine 10V, Negative-QTOF | splash10-00di-0000900000-fa1ca7afb7582d14c164 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clofazimine 20V, Negative-QTOF | splash10-00fr-0000900000-74b5c4b76177eb417437 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clofazimine 40V, Negative-QTOF | splash10-001i-8014900000-27f589888478cc331350 | 2021-10-11 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00845 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00845 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00845 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 21159573 |
---|
KEGG Compound ID | C06915 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Clofazimine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 2794 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 3749 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | Not Available |
---|